72 related articles for article (PubMed ID: 3442638)
1. [Plasma fibronectin level in patients with moyamoya disease].
Sasaki O; Tanaka R; Koike T; Takeuchi S; Takizawa T; Ishi R; Arai H
No To Shinkei; 1987 Nov; 39(11):1069-73. PubMed ID: 3442638
[TBL] [Abstract][Full Text] [Related]
2. Cerebral hemodynamics and oxygen metabolism in patients with moyamoya syndrome associated with atherosclerotic steno-occlusive arterial lesions.
Kato H; Shimosegawa E; Oku N; Kimura Y; Kajimoto K; Tanaka M; Hori M; Kitagawa K; Hatazawa J
Cerebrovasc Dis; 2008; 26(1):9-15. PubMed ID: 18511866
[TBL] [Abstract][Full Text] [Related]
3. The clinical features of adult unilateral moyamoya disease: does it have the same clinical characteristics as typical moyamoya disease?
Ogata T; Yasaka M; Inoue T; Yasumori K; Ibayashi S; Iida M; Okada Y
Cerebrovasc Dis; 2008; 26(3):244-9. PubMed ID: 18648196
[TBL] [Abstract][Full Text] [Related]
4. Plasma fibronectin in peripheral arterial disease.
Rus HG; Cucuianu AM; Galea F; Cristea A; Uza G; Cucuianu M
Med Interne; 1985; 23(4):271-6. PubMed ID: 3937216
[TBL] [Abstract][Full Text] [Related]
5. [Determination of plasma fibronectin (Fn) levels. Comparison between normal subjects and patients with various pathological conditions].
Gironi A; Niccolai J; Fabbri LP; Niccolai M; Chisci C
Quad Sclavo Diagn; 1982 Dec; 18(4):392-405. PubMed ID: 6764670
[TBL] [Abstract][Full Text] [Related]
6. Distribution of thrombotic lesions in the cerebral arteries in spontaneous occlusion of the circle of Willis: cerebrovascular moyamoya disease.
Ikeda E; Hosoda Y
Clin Neuropathol; 1993; 12(1):44-8. PubMed ID: 8440079
[TBL] [Abstract][Full Text] [Related]
7. [Plasma fibronectin in chronic liver diseases].
Soresi M; Di Martino D; Montalto G; Carroccio A; Ruggeri MI; Bascone F; Ippolito S; Notarbartolo A
Recenti Prog Med; 1993 Sep; 84(9):602-7. PubMed ID: 8210624
[TBL] [Abstract][Full Text] [Related]
8. Clinical and experimental pathology of Moyamoya disease.
Rao M; Zhang H; Liu Q; Zhang S; Hu L; Deng F
Chin Med J (Engl); 2003 Dec; 116(12):1845-9. PubMed ID: 14687471
[TBL] [Abstract][Full Text] [Related]
9. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
10. [Plasma fibronectin in chronic liver disease--marker of fibrosis?].
Simon K; Zalewska M; Gładysz A; Rotter K; Piszko P; Głowacki A
Przegl Lek; 1995; 52(4):129-32. PubMed ID: 7638358
[TBL] [Abstract][Full Text] [Related]
11. [Follow-up study on the relationship between age at onset of illness and outcome in patients with moyamoya disease].
Moritake K; Handa H; Yonekawa Y; Taki W; Okuno T
No Shinkei Geka; 1986 Jul; 14(8):957-63. PubMed ID: 3748299
[TBL] [Abstract][Full Text] [Related]
12. Determination of plasma fibronectin and serum C-reactive protein in patients with cerebrovascular events.
Pençe S; Yilmaz G; Yilmaz N; Kocoglu H; Namiduru E; Yüncü M; Gökalp N
Int J Clin Pract; 2003 Mar; 57(2):91-5. PubMed ID: 12661789
[TBL] [Abstract][Full Text] [Related]
13. [Clinical significance of posterior cerebral artery stenosis/occlusion in moyamoya disease].
Kuroda S; Ishikawa T; Houkin K; Iwasaki Y
No Shinkei Geka; 2002 Dec; 30(12):1295-300. PubMed ID: 12491581
[TBL] [Abstract][Full Text] [Related]
14. Role of transforming growth factor-beta1 in the pathogenesis of moyamoya disease.
Hojo M; Hoshimaru M; Miyamoto S; Taki W; Nagata I; Asahi M; Matsuura N; Ishizaki R; Kikuchi H; Hashimoto N
J Neurosurg; 1998 Oct; 89(4):623-9. PubMed ID: 9761057
[TBL] [Abstract][Full Text] [Related]
15. [Changes in fibronectin concentration during therapeutic plasmapheresis. Therapeutic effectiveness of selective removal of fibronectin in immune complex pathology].
Vasil'ev SA; Savchenko VG; Gorodetskiĭ VM; Ermolin GA; Kotelianskiĭ VE
Ter Arkh; 1984; 56(6):35-9. PubMed ID: 6236575
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
Kowalski M
J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
[TBL] [Abstract][Full Text] [Related]
17. Thyroid antibodies are associated with stenotic lesions in the terminal portion of the internal carotid artery.
Tanaka M; Sakaguchi M; Yagita Y; Gon Y; Yoshikawa K; Takahashi T; Fukunaga R; Mochizuki H; Kitagawa K
Eur J Neurol; 2014 Jun; 21(6):867-73. PubMed ID: 24602238
[TBL] [Abstract][Full Text] [Related]
18. Pathology of so-called "spontaneous occlusion of the circle of Willis".
Hosoda Y
Pathol Annu; 1984; 19 Pt 2():221-44. PubMed ID: 6504578
[TBL] [Abstract][Full Text] [Related]
19. [What should we call this group of disease? (author's transl)].
Maki Y
No Shinkei Geka; 1976 Mar; 4(3):243-51. PubMed ID: 944865
[TBL] [Abstract][Full Text] [Related]
20. [Magnetic resonance imaging in moyamoya disease].
Fujita K; Shirakuni T; Kojima N; Tamaki N; Matsumoto S
No Shinkei Geka; 1986 Mar; 14(3 Suppl):324-30. PubMed ID: 3703130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
